Clinical trial shift: Asia gains ground as Europe's share of new drug tests declines

Pharmaceutical companies are increasingly conducting clinical trials in Asia, while Europe's share of new medicine testing is declining. The shift reflects lower costs, faster patient recruitment, and evolving regulatory environments in Asian countries. This trend could reshape global drug development timelines and access to novel therapies.